{"prompt": "['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', '15 CLINICAL TRIAL PROTOCOL AMENDMENTS', 'All appendices attached hereto and referred to herein are made part of this clinical trial protocol.', 'The Investigator should not implement any deviation from, or changes to the clinical trial protocol', 'without agreement by the Sponsor and prior review and documented approval/favorable opinion', 'from the IRB/IEC and/or notification/approval of health authorities (competent regulatory', 'authority) of an amendment, as required by local regulation, except where necessary to eliminate', 'an immediate hazard(s) to clinical trial patients, or when the change(s) involves only logistical or', 'administrative aspects of the trial. Any change agreed upon will be recorded in writing, the', 'written amendment will be signed by the Investigator and by the Sponsor and the signed', 'amendment will be filed with this clinical trial protocol.', 'Any amendment to the clinical trial protocol requires written approval/favorable opinion by the', 'IRB/IEC prior to its implementation, unless there are overriding safety reasons.', 'In case of substantial amendment to the clinical trial protocol, approval from the health authorities', '(competent regulatory authority) will be sought before implementation.', 'In some instances, an amendment may require a change to the informed consent form. The', 'Investigator must receive an IRB/IEC approval/favorable opinion concerning the revised informed', 'consent form prior to implementation of the change and patient signature should be re-collected if', 'necessary.', 'Property of the Sanofi Group - strictly confidential', 'Page 92', '(electronic 4.0)']['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', '16', 'BIBLIOGRAPHIC REFERENCES', '1. Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, Blankstein R, Dorbala S,', 'Sitek A, Pencina MJ, Di Carli MF. Improved cardiac risk assessment with noninvasive', 'measures of coronary flow reserve. Circulation. 011;124:2215-24.', '2. Marzilli M, Huqi A and Morrone D. Persistent Angina The Araba Phoenix of Cardiology. Am', 'J Cardiovasc Drugs. 2010;10 Suppl.1:27-32.', '3. Focardi M, Capati E, Affinito S, Urselli R and Marzilli M. Persistent angina after myocardial', 'revascularization: a case report. Heart Metab. 2006; 31:27-9.', '4. Patel M.R, Peterson E.D, Dai D, Brennan J.M, Redberg R.F, Anderson H.V et al. Low', 'Diagnostic Yield of Elective Coronary Angiography. N Engl J Med. 2010;362:886-95.', '5. Radico F, Cicchitti V, Zimarino M, De Catherina R. Angina pectoris and myocardial ischemia', 'in the absence of obstructive coronary artery disease: practical considerations for diagnosis', 'tests. J Am Coll Cadiol Intv. 2014;7:453-63.', '6. Olson MB, Kelsey SF, Matthews K, Shaw LJ, Sharaf BL, Pohost GM, et al. Symptoms,', 'myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE', 'Study. Eur Heart J. 2003;24:1506-14', \"7. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ et al. The Women's\", 'Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility', 'report. J Am Coll Cardiol. 1999;33:1453-61.', '8. Bugiardini R, Pozzati A, Ottani F, Morgagni GL, Puddu P. Vasotonic angina: a spectrum of', 'ischemic syndromes involving functional abnormalities of the epicardial and microvascular', 'coronary circulation. J Am Coll Cardiol. 1993;22:417-25.', '9. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF et al. Insights from the', \"NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender\", 'differences in traditional and novel risk factors, symptom evaluation, and gender-optimized', 'diagnostic strategies. J Am Coll Cardiol. 2006;47:S4-S20.', '10.Suzuki H. Different definition of microvascular angina. Eur J Clin Invest. 2015;45(12):1360-6', '11. Izzo P, Macchi A, De Gennaro L, Gaglione A, Di Biase M and Brunetti N.D. Recurrent', 'angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options. European', 'Heart Journal: Acute Cardiovascular Care. 2012;1(2):158-69.', '12. Opherk D, Zebe H, Weihe E, Mall G, D\u00fcrr C, Gravert B et al. Reduced coronary dilatory', 'capacity and ultrastructural changes of the myocardium in patients with angina pectoris but', 'normal coronary arteriograms. Circulation. 1981;63(4):817-25.', 'Property of the Sanofi Group - strictly confidential', 'Page 93', '(electronic 4.0)']\n\n###\n\n", "completion": "END"}